Learn about ABL’s Clinical Immunomonitoring at the 49th Annual DIA Conference in Boston, MA

The 49th Annual DIA Conference for Advancing Therapeutic Innovation and Regulatory Science takes place June 23-27 at the Boston Convention and Exhibition Center. ABL staff will be available to discuss ABL’s long history of preclinical immunomonitoring experience and the expansion to the development of new clinical immunomonitoring capabilities.

Conference Summary: Join more than 7,000 life sciences professionals more than 7,000 life sciences professionals at all levels and across all disciplines involved in the discovery, development, and life cycle management of medical products all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.